September 17, 2012
UC San Diego Moores Cancer Center launched a bold plan today, aimed at personalizing cancer treatment. The “My Answer to Cancer” team of oncologists, bioinformaticians, pathologists and geneticists pledges to “sequence” or analyze the DNA of large numbers of patients with cancer in order to match each patient to the…
November 30, 2017
…that a novel cancer therapy could be developed using pharmacological agents that target the biological clock machinery. That’s because tumorigenesis, the process of turning normal cells into cancer cells, disrupts normal circadian rhythms, he said. In addition, the machinery controlling the biological clock controls several biochemical pathways that are altered…
May 25, 2014
Researchers at the University of California, San Diego School of Medicine have identified a mutated gene common to adenosquamous carcinoma (ASC) tumors – the first known unique molecular signature for this rare, but particularly virulent, form of pancreatic cancer.
December 15, 2021
Nixon Foundation funds effort to study and treat macular dystrophy at Shiley Eye Institute. Currently, there are no effective treatments to slow or prevent genetic condition.
May 1, 2015
…large parts of a cell’s signaling network instead of targeting only a single receptor or cell signaling pathway.
September 22, 2022
With a $126 million grant from the National Institutes of Health, a multi-institution team of researchers at UC San Diego, Salk Institute and elsewhere has launched a new Center for Multiomic Human Brain Cell Atlas to describe human brain cells in unprecedented detail over a lifetime.
September 30, 2014
More than 600 health care and construction workers donned pink hard hats while forming a giant human ribbon at the UC San Diego Jacobs Medical Center construction site today in support of National Breast Cancer Awareness month.
September 17, 2020
…for convalescent plasma (CP) therapy, which involves infusing patients with antibodies extracted from the blood of donors who have successfully recovered from COVID-19, with the hope that the resulting boost to their immune systems will shorten the length and reduce the severity of the disease. Evidence that CP therapy works…
May 21, 2012
Research by a collaborative group of scientists from UC San Diego School of Medicine, UC San Francisco and Wake Forest School of Medicine has led to identification of an existing drug that is effective against Entamoeba histolytica. This parasite causes amebic dysentery and liver abscesses and results in the death…
February 16, 2023
UC San Diego researchers report that a late-stage, pre-clinical small molecule inhibitor reverses malignant hyper-editing by a protein that promotes silencing of the immune response, metastasis and therapeutic resistance in 20 different cancer types.
